Depression in the Early Stages of Huntington Disease
Authors:
- 4 October 2011
- journal article
- Published by Taylor & Francis in Neurodegenerative Disease Management
- Vol. 1 (5) , 407-414
Abstract
SUMMARY Huntington disease (HD) has traditionally been considered a movement disorder, but cognitive and psychiatric symptoms also prominently factor into its clinical presentation. Depression is one of the most common psychiatric disturbances in HD, with its prevalence highest in manifest disease during stage 2, but it is also present during the illness prodrome (the period before manifestation of motor symptoms). Identification and treatment of depression in individuals with the HD mutation is an essential part of clinical management in this population, especially owing to the high risk of suicide. This article summarizes what is currently known about the presentation and treatment of depression in the early stages of HD and provides advice to clinicians treating this population.Keywords
This publication has 40 references indexed in Scilit:
- Correlates of Apathy in Huntington's DiseaseThe Journal of Neuropsychiatry and Clinical Neurosciences, 2010
- Earliest functional declines in Huntington diseasePsychiatry Research, 2010
- Comorbidities of Obsessive and Compulsive Symptoms in Huntington's DiseaseJournal of Nervous & Mental Disease, 2010
- Long-term outcome of presymptomatic testing in Huntington diseaseEuropean Journal of Human Genetics, 2008
- Detection of Huntington's disease decades before diagnosis: the Predict-HD studyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- The current clinical management of Huntington's diseaseMovement Disorders, 2008
- Behavioural problems in Huntington's disease using the Problem Behaviours AssessmentGeneral Hospital Psychiatry, 2008
- Neural bases of dysphoria in early Huntington's diseasePsychiatry Research: Neuroimaging, 2008
- Psychiatric disorders in preclinical Huntington's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Critical Periods of Suicide Risk in Huntington’s DiseaseAmerican Journal of Psychiatry, 2005